← Home / Peptides / YourProtocol / Melanotan II: The Safety Risks and Legal Status
Peptides Peptides

Melanotan II: The Safety Risks and Legal Status

Melanotan II is a synthetic tanning peptide with a safety story that should come first, not last. It has never been FDA-approved for any use, and regulators in the US, UK, EU, and Australia have all issued public warnings against it. Beyond nausea, flushing, and spontaneous erections, it can darken existing moles and skin lesions, which can mask or mimic melanoma changes and interfere with skin-cancer monitoring.

⚠️
YourProtocol
YourProtocol Research
In-house · Synthesized from the cited primary sources
Daily time
5 min
Difficulty
Beginner
Sources
2
What the evidence says
What it is

Understand what's actually being sold

A synthetic analog of alpha-MSH (melanocyte-stimulating hormone), injected to darken skin by stimulating melanin production; it also produces off-target libido and erectile effects, the same chemical family PT-141 was derived from.

The shared chemical origin with PT-141 does not mean Melanotan II shares PT-141's approval or safety profile; it does not.

FDA, TGA, MHRA, HPRA public warnings
For this step
No product needed
The safety risk that should lead

Know the single most serious documented risk first

Melanotan II can darken existing moles and skin lesions, which can mask or mimic melanoma changes and interfere with skin-cancer monitoring. Anyone with a personal or family history of skin cancer or atypical moles carries meaningfully higher risk.

This is the safety story that should come first on any honest page about Melanotan II, not an afterthought below the tanning pitch.

FDA, TGA, MHRA, HPRA public warnings
For this step
No product needed
Legal status

Know where it stands

Never FDA-approved for any use, and no approval has ever been sought for tanning use. The FDA, Australia's TGA, the UK's MHRA, and Ireland's HPRA have all explicitly and publicly warned against it; the FDA has issued warning letters to sellers.

Public regulatory warnings across four separate countries is an unusually strong, consistent signal.

FDA, TGA, MHRA, HPRA public warnings
For this step
No product needed
Other documented effects

Know the rest of the safety picture

Other documented effects include nausea, flushing, and spontaneous or prolonged erections. Unregulated sourcing, contamination, wrong concentration, non-sterile handling, applies as with the rest of the gray-market peptide supply. Peter Attia has said its safety concerns outweigh its benefit in his own assessment.

None of this is gray-market rumor; it is the consistent documented picture across regulators and credible expert commentary.

Peter Attia, AMA #83; Huberman Lab peptide episode
For this step
No product needed
What it is

Melanotan II is a synthetic analog of alpha-MSH (melanocyte-stimulating hormone), promoted as an injectable tanning peptide that darkens skin by stimulating melanin production; it also has off-target libido and erectile effects, which is how PT-141 was derived from the same chemical family. This page leads with safety, because the honest evidence picture here is closer to a genuine risk story than a promising-early-data story.

Why it works▼
No FDA approval exists or has ever been sought for Melanotan II's tanning use. Global regulators, the FDA, Australia's Therapeutic Goods Administration, the UK's MHRA, and Ireland's HPRA, have explicitly and publicly warned against it, and the FDA has issued warning letters to sellers of this unapproved drug. The single most serious documented risk is that Melanotan II can darken existing moles and skin lesions, which can mask or mimic melanoma changes and interfere with skin-cancer monitoring; anyone with a personal or family history of skin cancer or atypical moles carries meaningfully higher risk. Other documented effects include nausea, flushing, and spontaneous or prolonged erections. Peter Attia has named Melanotan-II specifically among his evidence buckets, stating that its safety concerns outweigh its benefit in his assessment, with limited human data behind the tanning and sexual-function claims made for it. Andrew Huberman's second peptide episode, covering Melanotan among a group of related compounds, flags melanoma risk as animal-only data with no human trials supporting safety. Unregulated sourcing, contamination, wrong concentration, and non-sterile handling, applies as with the rest of the gray-market peptide supply.
The evidence
Sources 2
Primary sources behind this page, cited straight to the source: peer-reviewed papers and reporting. Select any to view it here.
1
Peter Attia, AMA #83: Peptides, evaluating the science, safety, and hype (Melanotan-II named in his evidence buckets)
Article · peterattiamd.com
2
Huberman Lab: Peptides, The Science, Uses & Safety, with Dr. Abud Bakri (Melanotan segment, flags melanoma risk)
Article · hubermanlab.com
Source viewer
Loading the first source…
Is this for you?
Good fit if
  • Anyone considering Melanotan II who needs the safety picture before anything else
  • Anyone with a personal or family history of skin cancer or atypical moles researching tanning peptides
  • Readers who want to know why regulators in four countries have warned against a specific peptide
  • Readers comparing Melanotan II to PT-141, its FDA-approved chemical relative
Cautions
  • Never FDA-approved for any use; regulators in the US, UK, EU, and Australia have issued public warnings against it.
  • Can darken existing moles and skin lesions, masking or mimicking melanoma changes; higher risk for anyone with a personal or family history of skin cancer or atypical moles.
  • Sold as an unregulated research chemical with no purity, sterility, or concentration guarantee.
  • Educational only, not medical advice; anyone monitoring moles or skin lesions should consult a dermatologist, not stop monitoring.
Common questions
Is Melanotan II safe?▾
No credible safety case has been made for it. It has never been FDA-approved, regulators in the US, UK, EU, and Australia have issued public warnings against it, and it can darken existing moles and skin lesions in a way that can mask or mimic melanoma changes.
Is Melanotan II the same as PT-141?▾
No. They come from the same alpha-MSH chemical family, and PT-141 was derived from Melanotan II's family, but PT-141 is FDA-approved (as Vyleesi) for a specific indication, while Melanotan II has never been approved for any use and carries a distinct, serious mole-darkening safety risk.
What is the biggest risk with Melanotan II?▾
It can darken existing moles and skin lesions, which can mask or mimic melanoma changes and interfere with skin-cancer monitoring. Anyone with a personal or family history of skin cancer or atypical moles carries meaningfully higher risk.
Related protocols
💊
Peptides
PT-141 / Bremelanotide: Evidence and Safety
Based on the work of YourProtocol
Get the next protocol first

New expert protocols and evidence updates, cited to the source. No spam; unsubscribe anytime.

Also good for: Healthier Skin

Not medical advice. This page is for education only and is not a substitute for professional medical care. Consult a qualified clinician before changing your health routine.
Editorial disclosure. This protocol is written and fact-checked by the YourProtocol editorial team directly from the primary sources cited below; it is not written or reviewed by any outside expert.

Melanotan II: The Safety Risks and Legal Status
Read the evidence
Read it